deltatrials
Completed NA INTERVENTIONAL 1-arm NCT04906499

Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion

Sponsor: North Carolina Translational and Clinical Sciences Institute

Updated 7 times since 2021 Last updated: May 16, 2023 Started: Aug 1, 2021 Primary completion: Sep 9, 2022 Completion: Sep 9, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04906499, this NA trial focuses on Anterior Cruciate Ligament Injuries and Arthritis and remains completed. Sponsored by North Carolina Translational and Clinical Sciences Institute, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshotRecruiting~Sep 2022 – ~May 2023 · 8 months · monthly snapshotRecruiting~May 2023 – ~Feb 2024 · 9 months · monthly snapshotCompleted~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Feb 2024 — Jul 2024 [monthly]

    Completed NA

  4. May 2023 — Feb 2024 [monthly]

    Completed NA

    Status: RecruitingCompleted

  5. Sep 2022 — May 2023 [monthly]

    Recruiting NA

Show 2 earlier versions
  1. Sep 2021 — Sep 2022 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  2. Jun 2021 — Sep 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • North Carolina Translational and Clinical Sciences Institute
  • University of North Carolina, Chapel Hill
Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations